A Study to Evaluate the Safety and Efficacy of C19-IG 20% in SARS-CoV-2 Infected Asymptomatic Ambulatory Outpatients

Clinical trial NCT04847141 · TERMINATED

Trial details

NCT number: NCT04847141
Sponsor: Grifols Therapeutics LLC
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

COVID-19 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection

Start date: 2021-04-28
Primary completion: 2021-11-10
Enrollment: 465

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.